Saturday, November 12, 2016

J&J arthritis drug goes up against Humira, with mixed results

Nov 12 (Reuters) - Johnson & Johnson said its

experimental sirukumab treatment for rheumatoid arthritis showed

mixed results against AbbVie Inc's top-selling Humira

in a large trial.

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)